JP2025508676A5 - - Google Patents
Info
- Publication number
- JP2025508676A5 JP2025508676A5 JP2024545962A JP2024545962A JP2025508676A5 JP 2025508676 A5 JP2025508676 A5 JP 2025508676A5 JP 2024545962 A JP2024545962 A JP 2024545962A JP 2024545962 A JP2024545962 A JP 2024545962A JP 2025508676 A5 JP2025508676 A5 JP 2025508676A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- adenovirus vector
- acid sequence
- seq
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263305979P | 2022-02-02 | 2022-02-02 | |
| US63/305,979 | 2022-02-02 | ||
| US202263375803P | 2022-09-15 | 2022-09-15 | |
| US63/375,803 | 2022-09-15 | ||
| US202263384075P | 2022-11-16 | 2022-11-16 | |
| US63/384,075 | 2022-11-16 | ||
| US202263434815P | 2022-12-22 | 2022-12-22 | |
| US63/434,815 | 2022-12-22 | ||
| PCT/US2023/061878 WO2023150638A2 (en) | 2022-02-02 | 2023-02-02 | Omicron coronavirus vaccine constructs and methods of making and using same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025508676A JP2025508676A (ja) | 2025-04-10 |
| JP2025508676A5 true JP2025508676A5 (enExample) | 2026-02-10 |
Family
ID=87552962
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024545962A Pending JP2025508676A (ja) | 2022-02-02 | 2023-02-02 | オミクロンコロナウイルスワクチンコンストラクトならびにこれを作製および使用する方法 |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP4473122A4 (enExample) |
| JP (1) | JP2025508676A (enExample) |
| KR (1) | KR20240137110A (enExample) |
| CN (1) | CN120282795A (enExample) |
| AU (1) | AU2023216258A1 (enExample) |
| CA (1) | CA3243465A1 (enExample) |
| WO (1) | WO2023150638A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250228929A1 (en) * | 2022-04-03 | 2025-07-17 | Icahn School Of Medicine At Mount Sinai | Recombinant newcastle disease viruses and immunogenic compositions for use in immunizing against sars-cov-2 omicron variant |
| CN116987184B (zh) * | 2023-09-26 | 2024-01-12 | 北京百普赛斯生物科技股份有限公司 | 新型冠状病毒bq.1.1突变株特异性抗体及其应用 |
| WO2025202543A1 (en) * | 2024-03-28 | 2025-10-02 | Rokote Laboratories Finland Oy | A vaccine composition comprising an adenoviral vector and an adenoviral vector delivery enhancing agent |
| WO2025250851A1 (en) * | 2024-05-29 | 2025-12-04 | Washington University | Trivalent pan-sarbecovirus mucosal vaccine constructs and methods of making and using same |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5661476B2 (ja) * | 2008-03-04 | 2015-01-28 | ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア | サルアデノウイルスＳＡｄＶ−３６、−４２．１、−４２．２および−４４ならびにそれらの用途 |
| IL295548A (en) * | 2020-02-14 | 2022-10-01 | Altimmune Inc | Immunogenic compositions of the corona virus and their uses |
| MX2022013934A (es) * | 2020-05-07 | 2023-02-22 | Icahn School Med Mount Sinai | Virus de la enfermedad de newcastle recombinante que expresa la proteina de espicula de sars-cov-2 y usos del mismo. |
| JP2023529124A (ja) * | 2020-06-01 | 2023-07-07 | ワシントン・ユニバーシティ | コロナウイルスワクチンコンストラクトおよびこれを作製し使用する方法 |
-
2023
- 2023-02-02 KR KR1020247029519A patent/KR20240137110A/ko active Pending
- 2023-02-02 EP EP23750408.9A patent/EP4473122A4/en active Pending
- 2023-02-02 AU AU2023216258A patent/AU2023216258A1/en active Pending
- 2023-02-02 JP JP2024545962A patent/JP2025508676A/ja active Pending
- 2023-02-02 WO PCT/US2023/061878 patent/WO2023150638A2/en not_active Ceased
- 2023-02-02 CN CN202380033194.2A patent/CN120282795A/zh active Pending
- 2023-02-02 CA CA3243465A patent/CA3243465A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025508676A5 (enExample) | ||
| JP2023512519A5 (enExample) | ||
| KR100996330B1 (ko) | Ｈｉｖ 조절/부속 단백질의 융합 단백질 | |
| JP2025184979A5 (enExample) | ||
| JP2019502371A (ja) | マイクロｒｎａ認識エレメントを含むｃｍｖベクター | |
| Khanna et al. | Evolutionary dynamics of genetic variation in Epstein-Barr virus isolates of diverse geographical origins: evidence for immune pressure-independent genetic drift | |
| WO2021220246A1 (en) | Recombinant sars-cov-2 polypeptides and uses | |
| EP4114453A1 (en) | Vaccine against african swine fever virus infection | |
| JP2023522154A5 (enExample) | ||
| EP3970741A1 (en) | Stabilised superoxide dismutase (sod) homolog gene and uses thereof | |
| US20250026793A1 (en) | Chimeric betacoronavirus spike polypeptides | |
| CN118076646A (zh) | 一种可诱导广谱中和活性重组多组分新冠病毒三聚体蛋白疫苗的制备及应用 | |
| JP2023529124A5 (enExample) | ||
| Zou et al. | Recombination of host cell mRNA with the Asia 1 foot-and-mouth disease virus genome in cell suspension culture | |
| WO2006038742A1 (ja) | 組み換えウイルスおよびその用途 | |
| JP4797149B2 (ja) | インフルエンザウイルスに対するベクターワクチン | |
| CN118119646A (zh) | 一种可诱导广谱中和活性重组五组分新冠病毒三聚体蛋白疫苗的制备及应用 | |
| KR102616012B1 (ko) | 당화된 돼지 인터페론-알파를 발현하는 재조합 베큘로바이러스 | |
| US5430135A (en) | DNA sequence encoding a cynomolgus monkey hepatitis A virus capsid protein | |
| Reiss et al. | Newly synthesized class II MHC chains are required for VSV G presentation to CTL clones | |
| RU2021128662A (ru) | Нуклеиновая кислота и вакцина против коронавируса с её использованием | |
| CN117210496A (zh) | 一种新型冠状病毒的免疫原及其应用 | |
| US20220257747A1 (en) | Methods and compositions of astrovirus replicons | |
| WO2024105539A1 (en) | Recombinant lsdv vectored bovine coronavirus antigen constructs | |
| EP4282429A1 (en) | Multivalent covid-19 vaccines based on adenoviral vectors |